TABLE 2b.
Biochemical parameters’ ANOVA output and pairwise comparison.
| ANOVA (Two-way interaction) | PLA vs. N20 | PLA vs. CAF | PLA vs. CAF+N20 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F(3,39) | p | η2 | p | d | MD | 95% CI | p | d | MD | 95% CI | p | d | MD | 95% CI | |
| GLC (mmol · l-1) | 9.99 | < 0.01 | 0.49 | NS | 0.06 | 0.06 | -0.56 to 0.69 | < 0.01 | 0.86 | -0.75 | -1.39 to -0.12 | < 0.001 | 0.96 | -0.93 | -1.61to -0.27 |
| AST (UI · l-1) | 4.42 | < 0.01 | 0.28 | NS | 0.07 | -0.92 | -13.1 to 11.3 | NS | 0.08 | -1.64 | -13.8 to 10.5 | < 0.001 | 1.52 | -21.2 | -33.4 to -9.04 |
| CK (UI · l-1) | 1.03 | NS | 0.14 | NS | 0.36 | -33.9 | -71.5 to 3.67 | < 0.001 | 0.8 | -58.9 | -96.5 to -21.3 | < 0.01 | 0.76 | -54.3 | -91.1 to -16.7 |
| URE (mmol · l-1) | 4 | < 0.05 | 0.29 | NS | 0.06 | 0.06 | -0.56 to 0.69 | < 0.05 | 0.74 | -0.68 | -1.28 to -0.09 | < 0.001 | 1.31 | -0.99 | -1.58to -0.39 |
| GPx (U · gHB-1) | 1.26 | NS | 0.13 | NS | 0.53 | -18.4 | -39.1 to 2.39 | NS | 0.19 | 6.14 | -14.6 to 26.9 | NS | 0.34 | -12.1 | -32.8 to 8.68 |
| SOD (U · gHB-1) | 2.84 | < 0.05 | 0.24 | < 0.001 | 1.16 | -410 | -625 to -195 | NS | 0.78 | -305 | -567 to -41 | < 0.001 | 0.91 | -339 | -554 to -123 |
Note: RAST; the Running-based Anaerobic Sprint test, [La]: Plasma Lactate, Pmax: maximum power during the RAST, Pmean; mean power during the RAST, Pmin; minimum power during the RAST, W; watts, ANOVA; analysis of variance, N20; 20 min nap opportunity, CAF; 5 mg · kg-1 of caffeine, CAF+N20; 5 mg · kg-1 of caffeine + 20 min nap opportunity, F; Fisher’s F, p; probability, η2; Eta-squared, d; Cohen’s effect size, MD; Mean difference, 95% CI; 95% confidence Interval, NS; Non-significant, GLC; Plasma Glucose, AST; Aspartate Aminotransferase, CK; Creatine Kinase, URE; Urea, GPx; Glutathione Peroxidase and SOD; Superoxide Dismutase.